Archives: Agenda

The ongoing road to clinical trials from a startup perspective: Bench to bedside with a novel pan-cancer target

  • Human endogenous retrovirus (HERV) sequences comprise 8% of the total human genome DNA, and they entered the genome between 10 and 50 million years ago
  • HERVs are unique tumor targets that are overexpressed in more than 80% of solid tumors, but not in normal tissues
  • SunnyBay Biotech has developed therapeutics targeting the HERV-K supergroup of HERVs
  • Our approach for moving novel HERV-K therapeutic antibody-drug conjugates (ADCs), which reduce tumor growth, inhibit metastasis, and prolong survival in murine models of breast and lung cancers, from the lab into the clinic will be discussed

Keynote: Purpose, Partnerships, and the Future of Health in Retail

  • Rising consumer demand for healthier diets, but big education gaps remain
  • Shifting consumption: risks in declining categories, opportunities in convenience
  • HFSS regulations reshaping the retail and health landscape
  • Co-op x The Gut Stuff: an unexpected partnership driving purpose-led change

 

Keynote: From Curiosity to Craving: How Storytelling Wins the Modern Food & Drink Consumer

  • Captivating the digital audience… how to inspire trust in a fast-evolving food & drink industry
  • Friendship & community as brand superpowers… building authentic connections that resonate
  • Why old-school ads fail… and how entertainment + inspiration drive behaviour change
  • Education by stealth… engaging audiences without “lecturing” them
  • The seismic shift in entertainment consumption… what it means for your brand
  • Proven model for behaviour change… turning curiosity into demand